How can ophthalmology combat shrinking supplies of specialists in the fields of neuroophthalmology, pediatric ophthalmology, and uveitis? Step one: address the myths that surround these fields.
The April CME supplement from MedEdicus can be found here: Below the Surface: Targeting Corneal Nerves in the Treatment of Ocular Conditions.
Advertisement
Explore TEPEZZA® (teprotumumab-trbw) now for your patients with this serious, progressive disease.

TEPEZZA is a trademark owned by or licensed to Horizon. © 2022 Horizon Therapeutics plc P-TEP-US-00805 12/22
|